Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

Van Poppel, Hendrik; Roobol, Monique J.; Chapple, Christopher R.; Catto, James W. F.; N'Dow, James; Sonksen, Jens; Stenzl, Arnulf; Wirth, Manfred

dc.contributor.author	Stenzl, Arnulf
dc.date.accessioned	2022-07-04T08:48:47Z
dc.date.available	2022-07-04T08:48:47Z
dc.date.issued	2021
dc.identifier.issn	0302-2838
dc.identifier.uri	http://hdl.handle.net/10900/128987
dc.language.iso	en	de_DE
dc.publisher	Amsterdam	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.eururo.2021.07.024	de_DE
dc.subject.ddc	610	de_DE
dc.title	Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00558
utue.publikation.seiten	703-711	de_DE
utue.personen.roh	Van Poppel, Hendrik
utue.personen.roh	Roobol, Monique J.
utue.personen.roh	Chapple, Christopher R.
utue.personen.roh	Catto, James W. F.
utue.personen.roh	N'Dow, James
utue.personen.roh	Sonksen, Jens
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Wirth, Manfred
dcterms.isPartOf.ZSTitelID	European Urology	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	80	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE